Confirmed speakers and topics

Doris-Eva Bamiou, MD, MSc, PhD, DoH, HEFCE
Clinical Senior Lecturer & Consultant in Audiovestibular Medicine, UCL Ear Institute, London, UK
”Auditory processing and PAX6”
Not able to attend, video presentation.

David R. FitzPatrick,MD, FRCP
Professor and Consultant in Clinical Genetics, MRC Human Genetics Unit, Western General Hospital, Edinburgh, UK
"Aniridia with no detectable mutation at the PAX6 locus"

Irene Gottlob, MD, UnivDoz, FRCOphth
Professor of Ophthalmology, University of Leicester, Leicester Royal Infirmary, Leicester, UK
"Foveal morphology and eye movements in patients with PAX6 mutations"

James D. Lauderdale, PhD
Associate Professor, The University of Georgia, Department of Cellular Biology, Athens, Georgia, USA
”PAX6 and limbal stem cells”

Anthony Moore, MA, FRCS, FRCOphth
Professor of Ophthalmology, Honorary Consultant Moorfields Eye Hospital / Great Ormond Street Hospital, London, UK
“The spectrum of eye disease associated with PAX6 mutations”

Jill A. Nerby
Founder and Director of Aniridia Foundation International, Congenital Eye Disorder Manager, Department of Ophthalmology, University of Virginia School of Medicine, Charlottesville, Virginia, USA
”Living with aniridia”

Peter A. Netland, MD, PhD
Professor and Chairman of the Department of Ophthalmology, University of Virginia School of Medicine, Charlottesville, Virginia, USA
”Glaucoma in aniridia”

Elizabeth M. Simpson, PhD
Senior scientist, Professor, Centre for Molecular Medicine and Therapeutics, Department of Medical Genetics, University of British Columbia, Canada
"Aniridia Gene Therapy: Pre-Clinical studies"

Veronica van Heyningen, DPhil, FRS, FRSE, FMedSci
Professor, MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, Edinburgh, UK
”Mutational spectrum for aniridia, genotype-phenotype correlation, and the lessons for understanding gene function from disease”

Kathryn Colby, MD, PhD
Surgeon in Ophthalmology, Cornea Service, Massachusetts Eye and Ear Infirmary; Attending Ophthalmologist, Children’s Hospital Boston; Associate Professor of Ophthalmology, Harvard Medical School, Boston, MA, USA
“The Boston keratoprosthesis for aniridia: avoiding complications and optimizing outcomes”

Liv Kari Droslum, MD, PhD
Head of section, Department of Ophthalmology, Oslo University Hospital and Professor, University of Oslo, Norway
"Cataract and corneal surgery in aniridia"

Morten Carstens Moe, MD, PhD
Consultant, Department of Ophthalmology, Oslo University Hospital and Assistant professor, University of Oslo, Norway
"Ex vivo expanded autologous limbal epithelial cells on amniotic membrane using a culture medium with human serum as single supplement"

Mahinda Yogarajah, MD, PhD
Clinical research fellow, Institute of Neurology, Queen Square, London and specialist Registrar, National Hospital for Neurology and Neurosurgery, Queen Square, London, UK
"PAX6 and Advanced Brain Imaging"

Ulla Edén, MD, PhD
University of Linköping, Sweden
"Epidemiology and 8 years follow-up study of Scandinavian aniridia patients"

Per Fagerholm, Professor MD PhD
Department of Ophthalmology, University of Linköping, Sweden
"The surface of the eye in Aniridia"

Christopher D. Riemann, M.D.
Vitreoretinal Surgeon, Cincinnati Eye Institute,Cincinnati, Ohio, USA.
"Aniridia: A Vitreoretinal Perspective"

John Freeman, M.D.
Memphis Eye & Cataract Associates (MECA)
Instructor, University of Tennessee Health Science Center
Memphis, Tennessee   USA
"Aniridic Keratopathy: causes and treatments"